Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

EN
R&D Capability
Home  >  Innovation  >  R&D Capability
R&D and Innovation
Our Company has one of the largest R&D teams among pharmaceutical companies in China. We have several national- level R&D designations, including the National Technology Center* (國家級技術中心), Post- doctoral Research Station* (博士後科研工作站) and Key National Laboratory* (國家重點實驗室).
7
launched innovative drugs
30 +
innovative drug programs in different clinical stages
50 +
clinical trials of innovative drugs
60 +
national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
2
second prizes of National Science and Technology Progress Award
2
China Patent Gold Award
600 +
authorized invention patents at home and abroad
200 +
contributions to national standards
R&D Team
Golbal
R&D centers
1700+
R&D fellows at home and abroad
3
enjoy State Council Special Allowance
1
enrolled in the 100 and 1000 and 10000 National Talents Program